Skip to content
BIO Coffee Chat: MFN proposals would harm innovation and access
Most Favored Nation (MFN) type drug pricing proposals that were proposed by the ...
Read More
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription ...
Read More
NIH Director says no studies link vaccines and autism in hearing on modernization
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies ...
Read More
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new ...
Read More
BIO tells Congress how to maintain US biotech leadership
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate ...
Read More
Program harnesses the power of mentorship for patient organization leaders
In 2020, the Milken Institute launched the FasterCures LeadersLink Program to build capacity ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Federal Policy
BIO Coffee Chat: MFN proposals would harm innovation and access
Most Favored Nation (MFN) type drug pricing proposals that were proposed by the Centers for Medicare & Medicaid Innovation (CMMI) in December 2025 would weaken ...
Federal Policy
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Federal Policy
NIH Director says no studies link vaccines and autism in hearing on modernization
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies indicating a link between any vaccine and autism as Senators pushed for ...
Federal Policy
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of pharmacy ...
Federal Policy
BIO tells Congress how to maintain US biotech leadership
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate federal actions can support this leadership, the Biotechnology Innovation Organization (BIO) said ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the ...
Read More
